echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > 335 domestic anticancer drugs are not actively reduced in price and will be suspended from online purchase

    335 domestic anticancer drugs are not actively reduced in price and will be suspended from online purchase

    • Last Update: 2019-02-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [China Pharmaceutical network industry trends] on February 15, 2019, Heilongjiang Provincial Drug Centralized Purchase Center issued the notice on further reducing the tax and price of anticancer drugs (hereinafter referred to as the notice) According to the notice, 335 domestic anti-cancer drugs that have been purchased centrally in Heilongjiang Province and have not taken the initiative to reduce their prices will be cut down For those drugs that do not take the initiative to apply for price reduction without special reasons, the online purchase in Heilongjiang will be suspended According to the notice, the work of tax reduction and price reduction focuses on the domestic anti-cancer drugs that have been purchased centrally in Heilongjiang Province and have not been reduced Within the specified time limit, drug manufacturers can purchase drugs on the Internet in Heilongjiang province only through the procedures of commitment declaration, investigation and verification, and social publicity in accordance with the principle of no higher than the low price of other provinces in the country that have completed the tax reduction and price reduction In addition, green channels will be opened up for those anti-cancer drugs that belong to the list (batch) of anti-cancer drugs and are not centrally purchased in Heilongjiang Province At the same time, taking the tax reduction and price reduction as the access conditions for participating in online purchasing in Heilongjiang Province, according to the daily declaration and centralized treatment, the drug manufacturers can only purchase online in Heilongjiang Province through the procedures such as declaration commitment, investigation and verification, and social publicity, according to the principle of no higher than the low price of other provinces in the country that have completed the tax reduction and price reduction The time limit for declaration of pharmaceutical enterprises is March 4 In addition to Heilongjiang, Hainan, Liaoning and other provinces have also taken measures to cancel online procurement without price reduction On January 3, Hainan public resources trading center issued the notice of Hainan Province on publicizing the treatment results of price reduction of anticancer drugs in 2019, and 17 drugs were removed without price reduction The notice publicized the treatment results of the price reduction of anticancer drugs There are 8 varieties involved in the National Health Insurance Bureau's 103 varieties of anti-cancer drugs (13) without price reduction, 1 variety has submitted the application for price reduction, 1 variety has submitted the audit certificate of not enjoying tax rate reduction, and the other 6 varieties have not submitted materials According to the requirements of the provincial health insurance bureau, Hainan public resources trading center will withdraw the network for six varieties that have not submitted price reduction application or audit certificate In addition, as early as December 2018, the centralized purchase network of drugs and medical consumables of Liaoning Province released the notice on the implementation of the results of tax reduction and price reduction of domestic anti-cancer drugs According to the notice, 125 quality control drugs that are not affected by the tax reduction, apply for no price reduction, do not provide the accounting firm's relevant certification materials, and do not submit any materials will be suspended from online procurement in Liaoning Province from 0:00 on December 25, 2018 According to the industry, in 2019, many favorable policies and measures, such as anti-cancer drug zero tariff, anti-cancer drug collection, anti-cancer drug special negotiation, and anti-cancer drug API price reduction, point to anti-cancer drugs For example, the adjustment plan of provisional import and export tax rate is clear Since January 1, 2019, China has implemented provisional import tax rate on 706 commodities, and no export tariff will be imposed on 94 energy and resource industry commodities Among them, drug raw materials include a variety of anti-cancer drug raw materials and rare disease drug raw materials, and the tentative tax rate in 2019 is zero With the promotion of tax reduction and price reduction of anticancer drugs in various regions, it will also bring benefits to more cancer patients, further reduce the drug burden for patients, and improve the level of happiness of the people.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.